Fraud Enforcement, Compliance and Integrity in Health Reform: Meeting the Challenge When the Government Ups the Ante: Part Three of Three

WebinarLog-in information will be provided to registrants prior to the event.

Thursday, June 10, 2010
Thursday, June 17, 2010
Thursday, June 24, 2010
Registration Is Complimentary

Join Epstein Becker Green attorneys in a three-part webinar series on three successive Thursdays this month that will address the new compliance, integrity, and fraud, waste and abuse challenges in the health reform law. This program will discuss the enhancements made by the health reform law to the government's already enormous arsenal of fraud enforcement tools, address the law's new compliance and other obligations and analyze the impediments these provisions and existing fraud and abuse laws will have on achieving health reform's promise of transforming the health care system.

Following an overview in part one, parts two and three of this seminar series will be dedicated to discussing the implications of health reform's enforcement on specific industry sectors, including hospitals and health systems, pharmaceuticals and medical devices, payors and managed care, home care and others. Epstein Becker Green attorneys with experience in each sector will explore some of the key consequences and make practical recommendations for how health care entities can prepare for implementation of these health reform fraud enforcement provisions. The impact of these enforcement provisions on the conduct of due diligence activities being undertaken in anticipation of mergers, acquisitions and other business combinations and Board of Director responsibilities also will be discussed.

Part Three
Thursday, June 24, 2010

Click HERE to Register

In the third part of the program, Epstein Becker Green attorneys will provide commentary and analysis on the impact of the changes made by health reform to specific industries. The following industries and topics will be explored:

  • Government Payor Plans
  • Private Payor Plans
  • Pharmaceutical and Device Manufacturers
  • Transparency
  • Mandatory Compliance Programs
Clifford Barnes
Beth Essig
Sarah diFrancesca (Giesting)
Wendy Goldstein
Marci Handler